Medic Vision introduces FDA-pending SafeCT-29 to support XR-29 compliance

Medic Vision Imaging Solutions, the leading innovator of vendor-independent image enhancement solutions for low-dose CT exams, announced the introduction of SafeCT-29.

Designed to be CT-vendor neutral and compatible with the various makes and models of CT systems, SafeCT-29 is a seamless and cost effective solution that helps meeting the NEMA XR-29 (Smart Dose) standard and avoiding CMS penalties. The product will be demonstrated at the upcoming Radiological Society of North America (RSNA) Annual Meeting, November 30 – December 4 in Chicago.

NEMA estimated that one-third of the current CT installation base (4,000 scanners) would have to be replaced for the respective healthcare facility to avoid penalties, which are set at 5% in 2016 and 15% thereafter. The 4-slice, 8-slice some 16-slide CT scanners, as well as most PET/CT scanners are not supported by the original manufacturer to meet compliance.

"SafeCT-29 is on track to be the first and only non-OEM FDA-approved solution available to help healthcare facilities to achieve compliance for XR-29," said Eyal Aharon, CEO, Medic Vision.

"With the innovation and a commitment to improve healthcare affordably that sets Medic Vision apart from the rest, we can help eliminating the need to replace thousands of fully-operational scanners, increase the compliance with the "Smart Dose" mandate, and save the healthcare industry billions of dollars while increasing patient care."

Protected by two pending patents, SafeCT-29 is an innovative, add-on system that is easy to install and operate. It is fully automatic and enables the technologist to maintain his or her existing workflow.

SafeCT-29 connects to the CT console, analyzes dose data in real time, alerts the operator if the dose is too high, and prevents the patient scan until dose levels are changed or confirmed and justified.
Pending FDA approved, SafeCT-29 will be available directly from Medic Vision as well as through the company’s distribution partners.

*SafeCT-29 is pending FDA 510(k) clearance and is not yet available for sale in the U.S.